Cardiometabolic & kidneyResearch article
Treatment of Obstructive Sleep Apnea (OSA) and its Impact on Cardiovascular Disease, Part 2
- Narrative review
Study context
- Population
- Patients with OSA, particularly comorbid with insomnia, excessive sleepiness, obesity hypoventilation syndrome or chronic obstructive pulmonary disease
- Comparison
- CPAP vs no CPAP
Main finding
As reported in the abstract
Effect of CPAP treatment of OSA on CV outcomes
- Randomized controlled trials (RCTs): CPAP improves systemic hypertension, particularly in resistant hypertension with CPAP adherence
- Large RCTs: no long-term benefit of CPAP on hard CV outcomes
- Post hoc analyses: improved hard outcomes with adequate CPAP use
Original publication
Treatment of OSA and its Impact on Cardiovascular Disease, Part 2. J Am Coll Cardiol. Published 24 September 2024. doi:10.1016/j.jacc.2024.07.024
Summarised from the published abstract; every number is checked against it